🔗 Permalink

Inventor profile of:

Peter Kufer

City:

Munich

Country:

Germany

Published Applications:

Last publication date:

2026-05-14

Top Assignees for applications by Peter Kufer

The entities that hold a legal rights for patent applications filed by inventor Kufer Peter:

AMGEN RESEARCH (MUNICH) GMBH 43 Munich, Germany
Amgen Inc. 14 Thousand Oaks, CA United States
BOEHRINGER INGELHEIM INTERNATIONAL GMBH 2 Ingelheim am Rhein, Germany
MICROMET AG 2 Munich, Germany
VIB VZW 1 Ghent, Belgium
UNIVERSITEIT GENT 1 Ghent, Belgium
Amegen Research (Munich) GmbH 1 Muncih, Germany
Boehringer Ingellheim iInternational Gmbh 1 Ingelheim am Rhein, Germany

Recent patent applications by Kufer Peter

Peter Kufer from Munich, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-14

US20260132199A1

Chemistry; metallurgy

ANTIBODY CONSTRUCTS FOR DLL3 AND CD3

#2 | 2026-04-30

US20260116972A1

Chemistry; metallurgy

CROSS-SPECIES-SPECIFIC PSCAXCD3, CD19XCD3, C-METXCD3, ENDOSIALINXCD3, EPCAMXCD3, IGF-1RXCD3 OR FAPALPHAXCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

#3 | 2025-11-13

US20250346684A1

Chemistry; metallurgy

BINDING MOLECULES FOR BCMA AND CD3

#4 | 2025-11-06

US20250340639A1

Chemistry; metallurgy

ANTIBODY CONSTRUCTS FOR DLL3 AND CD3

#5 | 2025-10-30

US20250333537A1

Chemistry; metallurgy

PSMA AND CD3 BISPECIFIC T CELL ENGAGING ANTIBODY CONSTRUCTS

#6 | 2025-10-30

US20250333535A1

Chemistry; metallurgy

BISPECIFIC SINGLE CHAIN ANTIBODY CONSTRUCT WITH ENHANCED TISSUE DISTRIBUTION

#7 | 2025-09-11

US20250282863A1

Chemistry; metallurgy

ANTIBODY CONSTRUCTS FOR MSLN AND CD3

#8 | 2025-05-22

US20250163179A1

Chemistry; metallurgy

CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

#9 | 2025-05-22

US20250163177A1

Chemistry; metallurgy

BISPECIFIC T CELL ENGAGING ANTIBODY CONSTRUCTS

#10 | 2025-03-20

US20250092133A1

Chemistry; metallurgy

BISPECIFIC ANTIBODY CONSTRUCTS FOR CDH3 AND CD3

#11 | 2025-02-27

US20250064927A1

Human necessities

COMPOSITIONS COMPRISING CROSS-SPECIES-SPECIFIC ANTIBODIES AND USES THEREOF

#12 | 2024-12-05

US20240400673A1

Chemistry; metallurgy

ANTIBODY CONSTRUCTS FOR MSLN AND CD3

#13 | 2024-06-27

US20240209078A1

Chemistry; metallurgy

MULTITARGETING BISPECIFIC ANTIGEN-BINDING MOLECULES OF INCREASED SELECTIVITY

#14 | 2024-05-23

US20240166761A1

Chemistry; metallurgy

Single chain binding molecules comprising N-terminal ABP

#15 | 2024-01-11

US20240010724A1

Chemistry; metallurgy

Antibody Constructs for CDH19 and CD3

#16 | 2023-12-14

US20230398147A1

Human necessities

METHODS FOR ADMINISTERING THERAPEUTIC DOSES OF BISPECIFIC T-CELL ENGAGING MOLECULES FOR THE TREATMENT OF CANCER

#17 | 2023-10-05

US20230312717A1

Chemistry; metallurgy

ANTIBODY CONSTRUCTS FOR DLL3 AND CD3

#18 | 2023-06-22

US20230192884A1

Chemistry; metallurgy

BISPECIFIC T CELL ENGAGING ANTIBODY CONSTRUCTS

#19 | 2023-02-23

US20230057728A1

Chemistry; metallurgy

LONG LIFE POLYPEPTIDE BINDING MOLECULES

#20 | 2023-02-09

US20230041876A1

Chemistry; metallurgy

Bispecific antibody constructs for CDH3 and CD3

#21 | 2022-12-22

US20220403035A1

Chemistry; metallurgy

MULTITARGETING ANTIGEN-BINDING MOLECULES FOR USE IN PROLIFERATIVE DISEASES

#22 | 2022-11-10

US20220356268A1

Chemistry; metallurgy

Binding molecules for BCMA and CD3

#23 | 2022-08-11

US20220251243A1

Chemistry; metallurgy

BINDING MOLECULES FOR BCMA AND CD3

#24 | 2022-03-24

US20220088196A1

Human necessities

Means and Methods for Treating Tumorous Diseases

#25 | 2022-03-03

US20220064336A1

Chemistry; metallurgy

Binding molecules for BCMA and CD3

#26 | 2022-03-03

US20220064308A1

Chemistry; metallurgy

Nucleic acids encoding anitbody constructs binding EGFR VIII and CD3

#27 | 2022-02-10

US20220041736A1

Chemistry; metallurgy

Cross-species-specific single domain bispecific single chain antibody

#28 | 2021-10-07

US20210309743A1

Chemistry; metallurgy

Antibody constructs for DLL3 and CD3

#29 | 2021-09-30

US20210301017A1

Chemistry; metallurgy

PROLONGED ADMINISTRATION OF A BISPECIFIC ANTIBODY CONSTRUCT BINDING TO CD33 AND CD3

#30 | 2021-03-11

US20210070878A1

Chemistry; metallurgy

PSMA and CD3 Bispecific T Cell Engaging Antibody Constructs

#31 | 2020-11-19

US20200362039A1

Chemistry; metallurgy

CROSS-SPECIES-SPECIFIC PSCAXCD3, CD19XCD3, C-METXCD3, ENDOSIALINXCD3, EPCAMXCD3, IGF-1RXCD3 OR FAPALPHAXCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

#32 | 2020-10-22

US20200332002A1

Chemistry; metallurgy

Antibody constructs for DLL3 and CD3

#33 | 2020-05-07

US20200140558A1

Chemistry; metallurgy

Method for treating glioblastoma or glioma with antibody constructs for EGFRVIII and CD3

#34 | 2020-03-26

US20200095319A1

Chemistry; metallurgy

CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS

#35 | 2020-03-05

US20200071405A1

Chemistry; metallurgy

ANTIBODY CONSTRUCTS FOR CDH19 AND CD3

#36 | 2020-02-13

US20200048357A1

Chemistry; metallurgy

BCMA and CD3 bispecific T cell engaging antibody constructs

#37 | 2020-02-06

US20200040099A1

Chemistry; metallurgy

Single chain binding molecules comprising N-terminal ABP

#38 | 2019-08-29

US20190263907A1

Chemistry; metallurgy

Antibody constructs for DLL3 and CD3

#39 | 2019-06-06

US20190169310A1

Chemistry; metallurgy

CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

#40 | 2019-06-06

US20190169295A1

Chemistry; metallurgy

LONG LIFE POLYPEPTIDE BINDING MOLECULES

#41 | 2019-05-02

US20190127465A1

Chemistry; metallurgy

Administration of a bispecific construct binding to CD33 and CD3 for use in a method for the treatment of myeloid leukemia

#42 | 2019-03-07

US20190070290A1

Human necessities

Compositions comprising cross-species-specific antibodies and uses thereof

#43 | 2019-02-07

US20190040133A1

Chemistry; metallurgy

BISPECIFIC SINGLE CHAIN ANTIBODIES WITH SPECIFICITY FOR HIGH MOLECULAR WEIGHT TARGET ANTIGENS

#44 | 2019-01-17

US20190016805A1

Chemistry; metallurgy

Antibody constructs for CDH19 and CD3

#45 | 2018-05-24

US20180142021A1

Chemistry; metallurgy

Bispecific antibody constructs for CDH3 and CD3

#46 | 2018-01-04

US20180002450A1

Chemistry; metallurgy

Antibody constructs for CDH19 and CD3

#47 | 2017-12-07

US20170349668A1

Chemistry; metallurgy

Optimized cross-species specific bispecific single chain antibody contructs

#48 | 2017-11-16

US20170327581A1

Chemistry; metallurgy

Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains

#49 | 2017-09-28

US20170275373A1

Chemistry; metallurgy

BISPECIFIC SINGLE CHAIN ANTIBODY CONSTRUCT WITH ENHANCED TISSUE DISTRIBUTION

#50 | 2017-08-03

US20170218079A1

Chemistry; metallurgy

PSMA and CD3 bispecific T cell engaging antibody constructs

#51 | 2017-08-03

US20170218078A1

Chemistry; metallurgy

Bispecific T cell engaging antibody constructs

#52 | 2017-08-03

US20170218077A1

Chemistry; metallurgy

BCMA and CD3 bispecific T cell engaging antibody constructs

#53 | 2017-05-18

US20170137538A1

Chemistry; metallurgy

Pharmaceutical compositions with resistance to soluble CEA

#54 | 2017-05-04

US20170122947A1

Physics

Risk-stratification of B-precursor acute lymphoblastic leukemia patients

#55 | 2017-02-09

US20170037130A1

Chemistry; metallurgy

Antibody constructs for DLL3 and CD3

#56 | 2017-02-02

US20170029512A1

Chemistry; metallurgy

Antibody constructs for EGFRVIII and CD3

#57 | 2017-02-02

US20170029502A1

Chemistry; metallurgy

Antibody constructs for MSLN and CD3

#58 | 2016-09-15

US20160264671A1

Chemistry; metallurgy

Bispecific single chain antibodies with specificity for high molecular weight target antigens

#59 | 2016-06-23

US20160176973A1

Chemistry; metallurgy

Binding molecules for BCMA and CD3

#60 | 2016-06-02

US20160152707A1

Chemistry; metallurgy

CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS

#61 | 2016-05-05

US20160122436A1

Chemistry; metallurgy

SINGLE CHAIN BINDING MOLECULES COMPRISING N-TERMINAL ABP

#62 | 2016-02-11

US20160039948A1

Chemistry; metallurgy

Antibody constructs for influenza M2 and CD3

#63 | 2016-02-04

US20160032019A1

Chemistry; metallurgy

Antibody constructs for CDH19 and CD3

#64 | 2015-12-24

US20150368343A1

Chemistry; metallurgy

Antibody constructs for CDH19 and CD3

#65 | 2015-03-12

US20150071928A1

Chemistry; metallurgy

Dosage regimen for administering a CD19XCD3 bispecific antibody

#66 | 2015-02-05

US20150037334A1

Chemistry; metallurgy

LONG LIFE POLYPEPTIDE BINDING MOLECULES

#67 | 2015-01-22

US20150023967A1

Chemistry; metallurgy

Binding molecules for BCMA and CD3

#68 | 2014-11-27

US20140348837A1

Chemistry; metallurgy

Binding molecules for BCMA and CD3

#69 | 2014-10-30

US20140322218A1

Chemistry; metallurgy

Antibody Constructs for CDH19 and CD3

#70 | 2014-08-14

US20140228316A1

Human necessities

PPS for the prevention of potential adverse effects caused by CD3 specific binding domains

#71 | 2014-08-14

US20140227272A1

Chemistry; metallurgy

Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains

#72 | 2013-06-20

US20130156770A1

Chemistry; metallurgy

Binding molecules for BCMA and CD3

#73 | 2013-06-20

US20130156769A1

Chemistry; metallurgy

Binding molecules for BCMA and CD3

#74 | 2013-05-23

US20130129730A1

Chemistry; metallurgy

Cross-species-specific PSMAxCD3 bispecific single chain antibody

#75 | 2012-12-27

US20120328618A1

Chemistry; metallurgy

Dosage regimen for administering a CD19XCD3 bispecific antibody

#76 | 2012-09-27

US20120244161A1

Chemistry; metallurgy

DOSAGE REGIMEN FOR ADMINISTERING AN EpCAMxCD3 BISPECIFIC ANTIBODY

#77 | 2012-02-09

US20120034228A1

Chemistry; metallurgy

CROSS-SPECIES-SPECIFIC PSCAxCD3, CD19xCD3, C-METxCD3, ENDOSIALINxCD3, EPCAMxCD3, IGF-1RxCD3 OR FAPALPHAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

#78 | 2011-12-01

US20110293619A1

Chemistry; metallurgy

CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

#79 | 2011-11-10

US20110275787A1

Chemistry; metallurgy

Cross-species-specific single domain bispecific single chain antibody

#80 | 2011-10-27

US20110262439A1

Chemistry; metallurgy

Bispecific single chain antibodies with specificity for high molecular weight target antigens

#81 | 2008-12-11

US20080305105A1

Chemistry; metallurgy

BISPECIFIC ANTIBODIES

#82 | 2005-06-23

US20050136050A1

Chemistry; metallurgy

Bispecific antibodies

InventorID:

260840 ⎘